| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_751562df05f1831baef905641425c407 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-621
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-48038
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5153 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-621 |
| filingDate |
2016-09-29^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_abe8d1331857f76e9270365a1fa548a0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bae95a68a5594bf2c48366de0a53ec4a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5734d052d2d14f3241eb20517cccf914
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dfe78a098381dac40364b97f11550917 |
| publicationDate |
2017-03-30^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2017087167-A1 |
| titleOfInvention |
Modification of drugs for incorporation into nanoparticles |
| abstract |
Aspirin is chemically modified to generate a prodrug that releases aspirin in cellular milieu. The prodrug has a lipophilic tail that may enhance uptake efficiency in nanoparticles. Nanoparticles including the prodrugs may be effective for treating inflammatory disorders, including neurodegenerative disorders. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019262793-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102075391-B1 |
| priorityDate |
2015-09-29^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |